Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up. J. Pharm. Nutr. Sci. [Internet]. 2022 Dec. 13 [cited 2026 May 19];12:74-9. Available from: https://setpublisher.com/index.php/jpans/article/view/2440